Annual ROE
-67.23%
-40.75%-153.89%
December 31, 2023
Summary
- As of March 8, 2025, ZVRA annual return on equity is -67.23%, with the most recent change of -40.75% (-153.89%) on December 31, 2023.
- During the last 3 years, ZVRA annual ROE has fallen by -86.44% (-449.97%).
- ZVRA annual ROE is now -112.45% below its all-time high of 540.10%, reached on December 1, 2015.
Performance
ZVRA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-159.89%
-40.22%-33.61%
September 30, 2024
Summary
- As of March 8, 2025, ZVRA quarterly return on equity is -159.89%, with the most recent change of -40.22% (-33.61%) on September 30, 2024.
- Over the past year, ZVRA quarterly ROE has dropped by -93.03% (-139.14%).
- ZVRA quarterly ROE is now -118.49% below its all-time high of 864.51%, reached on March 1, 2016.
Performance
ZVRA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ZVRA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -153.9% | -139.1% |
| 3 y3 years | -450.0% | -139.1% |
| 5 y5 years | -179.3% | -139.1% |
ZVRA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -153.9% | at low | <-9999.0% | at low |
| 5 y | 5-year | -304.2% | at low | -348.0% | +37.7% |
| alltime | all time | -112.5% | at low | -118.5% | +37.7% |
Zevra Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -159.89%(+33.6%) |
| Jun 2024 | - | -119.67%(+53.9%) |
| Mar 2024 | - | -77.74%(+16.3%) |
| Dec 2023 | -67.23%(+153.9%) | -66.86%(+146.5%) |
| Sep 2023 | - | -27.12%(+32.9%) |
| Jun 2023 | - | -20.41%(-50.6%) |
| Mar 2023 | - | -41.35%(+59.7%) |
| Dec 2022 | -26.48%(-6.1%) | -25.90%(-15.7%) |
| Sep 2022 | - | -30.72%(+23.5%) |
| Jun 2022 | - | -24.88%(>+9900.0%) |
| Mar 2022 | - | -0.10%(-99.0%) |
| Dec 2021 | -28.19%(-246.7%) | - |
| Dec 2021 | - | -10.50%(-57.3%) |
| Sep 2021 | - | -24.57%(-90.4%) |
| Jun 2021 | - | -256.48%(-497.8%) |
| Mar 2021 | - | 64.47%(+228.8%) |
| Dec 2020 | 19.21%(-41.7%) | 19.61%(-5.6%) |
| Sep 2020 | - | 20.78%(+82.6%) |
| Jun 2020 | - | 11.38%(-53.3%) |
| Mar 2020 | - | 24.36%(-25.1%) |
| Dec 2019 | 32.93% | 32.54%(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | 32.25%(-38.6%) |
| Jun 2019 | - | 52.53%(-1.1%) |
| Mar 2019 | - | 53.12%(-23.5%) |
| Dec 2018 | 84.83%(+12.5%) | 69.47%(-11.2%) |
| Sep 2018 | - | 78.27%(-7.3%) |
| Jun 2018 | - | 84.45%(-11.0%) |
| Mar 2018 | - | 94.90%(-2.2%) |
| Dec 2017 | 75.43%(-14.6%) | 97.05%(-20.6%) |
| Sep 2017 | - | 122.16%(-32.8%) |
| Jun 2017 | - | 181.66%(-5.7%) |
| Mar 2017 | - | 192.64%(+15.6%) |
| Dec 2016 | 88.34%(-83.6%) | 166.63%(-18.0%) |
| Sep 2016 | - | 203.18%(+13.3%) |
| Jun 2016 | - | 179.35%(-79.3%) |
| Mar 2016 | - | 864.51%(+163.9%) |
| Dec 2015 | 540.10%(+971.4%) | 327.55%(+50.3%) |
| Sep 2015 | - | 217.99%(+32.1%) |
| Jun 2015 | - | 165.08%(+197.7%) |
| Mar 2015 | - | 55.46%(+10.0%) |
| Dec 2014 | 50.41%(+134.0%) | 50.41% |
| Dec 2013 | 21.54% | - |
FAQ
- What is Zevra Therapeutics annual return on equity?
- What is the all time high annual ROE for Zevra Therapeutics?
- What is Zevra Therapeutics annual ROE year-on-year change?
- What is Zevra Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly ROE year-on-year change?
What is Zevra Therapeutics annual return on equity?
The current annual ROE of ZVRA is -67.23%
What is the all time high annual ROE for Zevra Therapeutics?
Zevra Therapeutics all-time high annual return on equity is 540.10%
What is Zevra Therapeutics annual ROE year-on-year change?
Over the past year, ZVRA annual return on equity has changed by -40.75% (-153.89%)
What is Zevra Therapeutics quarterly return on equity?
The current quarterly ROE of ZVRA is -159.89%
What is the all time high quarterly ROE for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly return on equity is 864.51%
What is Zevra Therapeutics quarterly ROE year-on-year change?
Over the past year, ZVRA quarterly return on equity has changed by -93.03% (-139.14%)